What is the current annual EBITDA of DGX?

As of today, DGX annual EBITDA is $2.17B

What is 1-year change in DGX annual EBITDA?

DGX annual EBITDA is up +13.89% year-over-year

What is 3-year change in DGX annual EBITDA?

DGX annual EBITDA is up +5.54% over the past 3 years

How far is DGX annual EBITDA from its all-time high?

DGX annual EBITDA is currently -23.81% below its historical high of $2.85B set on December 31, 2021

How does DGX annual EBITDA rank versus sector peers?

DGX annual EBITDA is higher than 95.48% of companies in Healthcare sector

When is DGX next annual earnings release?

The next annual earnings release for DGX is on February 9, 2027

What is the current quarterly EBITDA of DGX?

As of today, DGX quarterly EBITDA is $632.00M

What is DGX quarterly EBITDA most recent change?

DGX quarterly EBITDA was up +3.61% on September 30, 2026

What is 1-year change in DGX quarterly EBITDA?

DGX quarterly EBITDA is up +12.46% year-over-year

How far is DGX quarterly EBITDA from its all-time high?

DGX quarterly EBITDA is currently -32.04% below its historical high of $930.00M set on December 31, 2020

How does DGX quarterly EBITDA rank versus sector peers?

DGX quarterly EBITDA is higher than 95.65% of companies in Healthcare sector

When is DGX next earnings release?

The next earnings release for DGX is on February 9, 2027

What is the current TTM EBITDA of DGX?

As of today, DGX TTM EBITDA is $2.33B

What is DGX TTM EBITDA most recent change?

DGX TTM EBITDA was up +3.09% on September 30, 2026

What is 1-year change in DGX TTM EBITDA?

DGX TTM EBITDA is up +8.71% year-over-year

How far is DGX TTM EBITDA from its all-time high?

DGX TTM EBITDA is currently -28.37% below its historical high of $3.26B set on June 30, 2021

How does DGX TTM EBITDA rank versus sector peers?

DGX TTM EBITDA is higher than 95.17% of companies in Healthcare sector

When is DGX next earnings release?

The next earnings release for DGX is on February 9, 2027

DGX EBITDA History & Chart Since 1996

Annual EBITDA

$2.17B$265.00M+13.89%

December 31, 2025

Summary

Current Value: As of today, DGX annual EBITDA is $2.17B, up +13.89% on December 31, 2025
Historical Performance: DGX annual EBITDA is up +5.54% over the past 3 years, down -11.88% over the past 5 years
All-Time High Comparison: DGX annual EBITDA is currently -23.81% below its historical high of $2.85B set on December 31, 2021
3-Year Low Comparison: DGX annual EBITDA is +21.40% above its 3-year low of $1.79B reached on December 31, 2023
Sector Comparison: DGX annual EBITDA is higher than 95.48% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

DGX Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$2.17B	+13.9%	+5.5%	-11.9%	+37.0%
Quarterly EBITDA	Sep 30, 26	$632.00M	+12.5%	+35.9%	-17.9%	+48.8%
TTM EBITDA	Sep 30, 26	$2.33B	+8.7%	+30.2%	-25.6%	+49.1%
Price	Nov 12, 26	$259.65	+39.0%	+95.5%	+73.1%	+351.3%
PE Ratio	Nov 12, 26	25.85	+17.9%	+29.7%	+186.9%	+22.2%
Annual Revenue	Dec 31, 25	$11.04B	+11.8%	+11.7%	+16.9%	+49.8%
Annual EPS	Dec 31, 25	$8.74	+14.1%	+9.5%	-16.9%	+115.9%
	Dec 31, 25	$1.60B	+13.3%	-1.2%	-23.9%	+20.4%
Annual Net Income	Dec 31, 25	$1.04B	+13.8%	+3.1%	-30.2%	+37.9%

EBITDA Highs

DGX Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$2.17B	Dec 31, 25	at high
5Y	$2.85B	Dec 31, 21	-23.8%
All	$2.85B	Dec 31, 21	-23.8%

EBITDA Lows

DGX Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$1.79B	Dec 31, 23	+21.4%
5Y	$1.79B	Dec 31, 23	+21.4%
All	$157.95M	Dec 31, 97	+1275.7%

EBITDA History

Year	Value	Change
2025	$2.17B	+13.9%
2024	$1.91B	+6.6%
2023	$1.79B	-13.1%
2022	$2.06B	-27.8%
2021	$2.85B	+15.7%
2020	$2.47B	+59.2%
2019	$1.55B	+1.0%
2018	$1.53B	-1.3%
2017	$1.55B	+5.1%
2016	$1.48B	-2.0%
2015	$1.51B	+5.2%
2014	$1.43B	-0.1%
2013	$1.44B	-10.3%
2012	$1.60B	+0.7%
2011	$1.59B	+0.2%

Year	Value	Change
2010	$1.59B	-1.2%
2009	$1.61B	+7.1%
2008	$1.50B	+11.7%
2007	$1.34B	-0.3%
2006	$1.35B	+11.7%
2005	$1.21B	+12.7%
2004	$1.07B	+12.7%
2003	$949.34M	+31.2%
2002	$723.84M	+29.5%
2001	$559.12M	+23.7%
2000	$452.11M	+86.2%
1999	$242.87M	+46.7%
1998	$165.58M	+4.8%
1997	$157.95M	-5.7%
1996	$167.57M	-

FAQ

What is the current annual EBITDA of DGX?: As of today, DGX annual EBITDA is $2.17B
What is 1-year change in DGX annual EBITDA?: DGX annual EBITDA is up +13.89% year-over-year
What is 3-year change in DGX annual EBITDA?: DGX annual EBITDA is up +5.54% over the past 3 years
How far is DGX annual EBITDA from its all-time high?: DGX annual EBITDA is currently -23.81% below its historical high of $2.85B set on December 31, 2021
How does DGX annual EBITDA rank versus sector peers?: DGX annual EBITDA is higher than 95.48% of companies in Healthcare sector
When is DGX next annual earnings release?: The next annual earnings release for DGX is on February 9, 2027

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$632.00M$22.00M+3.61%

September 30, 2026

Summary

Current Value: As of today, DGX quarterly EBITDA is $632.00M, up +3.61% on September 30, 2026
Historical Performance: DGX quarterly EBITDA is up +12.46% year-over-year, up +35.91% over the past 3 years
All-Time High Comparison: DGX quarterly EBITDA is currently -32.04% below its historical high of $930.00M set on December 31, 2020
3-Year Low Comparison: DGX quarterly EBITDA is +50.48% above its 3-year low of $420.00M reached on December 31, 2023
Sector Comparison: DGX quarterly EBITDA is higher than 95.65% of companies in Healthcare sector

Performance

DGX Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 30, 26	$632.00M	+3.6%	+12.5%	+35.9%	-17.9%
Annual EBITDA	Dec 31, 25	$2.17B	–	+13.9%	+5.5%	-11.9%
TTM EBITDA	Sep 30, 26	$2.33B	+3.1%	+8.7%	+30.2%	-25.6%
Price	Nov 12, 26	$259.65	+9.2%	+39.0%	+95.5%	+73.1%
PE Ratio	Nov 12, 26	25.85	+2.5%	+17.9%	+29.7%	+186.9%
Quarterly Revenue	Sep 30, 26	$3.10B	+1.8%	+10.0%	+35.0%	+11.6%
Quarterly EPS	Sep 30, 26	$2.77	-2.8%	+28.7%	+41.5%	-31.2%
	Sep 30, 26	$485.00M	+4.5%	+15.5%	+37.0%	-27.5%
Quarterly Net Income	Sep 30, 26	$324.00M	-2.7%	+26.1%	+37.9%	-38.3%

Quarterly EBITDA Highs

DGX Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$632.00M	Sep 30, 26	at high
3Y	$632.00M	Sep 30, 26	at high
5Y	$770.00M	N/A	-17.9%
All	$930.00M	Dec 31, 20	-32.0%

Quarterly EBITDA Lows

DGX Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$536.00M	Dec 31, 25	+17.9%
3Y	$420.00M	Dec 31, 23	+50.5%
5Y	$407.00M	Dec 31, 22	+55.3%
All	$27.70M	Dec 31, 97	+2181.6%

Quarterly EBITDA History

Month	Value	Change
Sep 2026	$632.00M	+3.6%
Jun 2026	$610.00M	+9.9%
Mar 2026	$555.00M	+3.5%
Dec 2025	$536.00M	-4.6%
Sep 2025	$562.00M	-1.1%
Jun 2025	$568.00M	+12.0%
Mar 2025	$507.00M	-0.4%
Dec 2024	$509.00M	+7.2%
Sep 2024	$475.00M	-2.5%
Jun 2024	$487.00M	+12.0%
Mar 2024	$435.00M	+3.6%
Dec 2023	$420.00M	-9.7%
Sep 2023	$465.00M	-1.7%
Jun 2023	$473.00M	+5.8%
Mar 2023	$447.00M	+9.8%
Dec 2022	$407.00M	-19.4%
Sep 2022	$505.00M	-1.8%
Jun 2022	$514.00M	-18.8%
Mar 2022	$633.00M	-2.9%
Dec 2021	$652.00M	-15.3%
Sep 2021	$770.00M	+18.1%
Jun 2021	$652.00M	-16.6%
Mar 2021	$782.00M	-15.9%
Dec 2020	$930.00M	+4.1%
Sep 2020	$893.00M	+149.4%
Jun 2020	$358.00M	+27.4%
Mar 2020	$281.00M	-27.2%
Dec 2019	$386.00M	-5.6%
Sep 2019	$409.00M	+0.2%
Jun 2019	$408.00M	+17.9%
Mar 2019	$346.00M	-1.7%
Dec 2018	$352.00M	-9.3%
Sep 2018	$388.00M	-6.7%
Jun 2018	$416.00M	+10.3%
Mar 2018	$377.00M	-0.5%
Dec 2017	$379.00M	-5.3%
Sep 2017	$400.00M	-2.2%
Jun 2017	$409.00M	+12.7%
Mar 2017	$363.00M	+1.1%
Dec 2016	$359.00M	-6.8%
Sep 2016	$385.00M	-1.0%
Jun 2016	$389.00M	+12.8%
Mar 2016	$345.00M	-0.3%
Dec 2015	$346.00M	-13.9%
Sep 2015	$402.00M	+2.6%
Jun 2015	$392.00M	+13.6%
Mar 2015	$345.00M	-4.7%
Dec 2014	$362.00M	-5.2%
Sep 2014	$382.00M	+1.1%
Jun 2014	$378.00M	+21.5%
Mar 2014	$311.00M	-12.3%
Dec 2013	$354.47M	-2.6%
Sep 2013	$363.79M	-2.8%
Jun 2013	$374.37M	+9.3%
Mar 2013	$342.38M	-5.3%
Dec 2012	$361.49M	-14.9%
Sep 2012	$425.00M	+0.5%
Jun 2012	$422.79M	+8.0%
Mar 2012	$391.42M	-2.2%
Dec 2011	$400.15M	-5.8%

Month	Value	Change
Sep 2011	$424.68M	+1.4%
Jun 2011	$418.75M	+21.1%
Mar 2011	$345.84M	-7.8%
Dec 2010	$375.18M	-6.4%
Sep 2010	$400.85M	-6.8%
Jun 2010	$430.05M	+13.3%
Mar 2010	$379.67M	-4.7%
Dec 2009	$398.54M	-3.4%
Sep 2009	$412.50M	+0.9%
Jun 2009	$408.66M	+5.9%
Mar 2009	$386.07M	-2.6%
Dec 2008	$396.38M	+3.6%
Sep 2008	$382.66M	+2.3%
Jun 2008	$373.89M	+7.8%
Mar 2008	$346.93M	-6.9%
Dec 2007	$372.48M	-0.4%
Sep 2007	$373.83M	+13.2%
Jun 2007	$330.36M	+24.1%
Mar 2007	$266.21M	-18.4%
Dec 2006	$326.33M	-4.3%
Sep 2006	$340.99M	+2.7%
Jun 2006	$331.87M	+3.4%
Mar 2006	$320.96M	+5.6%
Dec 2005	$303.99M	+3.4%
Sep 2005	$293.92M	-3.7%
Jun 2005	$305.25M	+12.0%
Mar 2005	$272.65M	+3.7%
Dec 2004	$262.87M	-4.1%
Sep 2004	$274.24M	-3.2%
Jun 2004	$283.17M	+13.3%
Mar 2004	$249.92M	+1.9%
Dec 2003	$245.31M	-3.4%
Sep 2003	$253.85M	-0.4%
Jun 2003	$254.95M	+27.4%
Mar 2003	$200.18M	+11.2%
Dec 2002	$179.98M	-6.2%
Sep 2002	$191.91M	-0.7%
Jun 2002	$193.17M	+21.7%
Mar 2002	$158.78M	+11.2%
Dec 2001	$142.81M	+0.4%
Sep 2001	$142.23M	-5.3%
Jun 2001	$150.22M	+21.3%
Mar 2001	$123.85M	+18.1%
Dec 2000	$104.88M	-11.9%
Sep 2000	$119.02M	-5.6%
Jun 2000	$126.06M	+26.2%
Mar 2000	$99.85M	+9.8%
Dec 1999	$90.92M	+34.0%
Sep 1999	$67.85M	+40.8%
Jun 1999	$48.18M	+22.8%
Mar 1999	$39.22M	+2.1%
Dec 1998	$38.40M	-0.9%
Sep 1998	$38.74M	-13.2%
Jun 1998	$44.61M	+1.8%
Mar 1998	$43.83M	+58.2%
Dec 1997	$27.70M	-26.3%
Sep 1997	$37.60M	-20.3%
Jun 1997	$47.20M	+22.9%
Mar 1997	$38.40M	-

FAQ

What is the current quarterly EBITDA of DGX?: As of today, DGX quarterly EBITDA is $632.00M
What is DGX quarterly EBITDA most recent change?: DGX quarterly EBITDA was up +3.61% on September 30, 2026
What is 1-year change in DGX quarterly EBITDA?: DGX quarterly EBITDA is up +12.46% year-over-year
How far is DGX quarterly EBITDA from its all-time high?: DGX quarterly EBITDA is currently -32.04% below its historical high of $930.00M set on December 31, 2020
How does DGX quarterly EBITDA rank versus sector peers?: DGX quarterly EBITDA is higher than 95.65% of companies in Healthcare sector
When is DGX next earnings release?: The next earnings release for DGX is on February 9, 2027

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$2.33B$70.00M+3.09%

September 30, 2026

Summary

Current Value: As of today, DGX TTM EBITDA is $2.33B, up +3.09% on September 30, 2026
Historical Performance: DGX TTM EBITDA is up +8.71% year-over-year, up +30.19% over the past 3 years
All-Time High Comparison: DGX TTM EBITDA is currently -28.37% below its historical high of $3.26B set on June 30, 2021
3-Year Low Comparison: DGX TTM EBITDA is +30.19% above its 3-year low of $1.79B reached on an earlier date
Sector Comparison: DGX TTM EBITDA is higher than 95.17% of companies in Healthcare sector

Performance

DGX Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 30, 26	$2.33B	+3.1%	+8.7%	+30.2%	-25.6%
Annual EBITDA	Dec 31, 25	$2.17B	–	+13.9%	+5.5%	-11.9%
Quarterly EBITDA	Sep 30, 26	$632.00M	+3.6%	+12.5%	+35.9%	-17.9%
Price	Nov 12, 26	$259.65	+9.2%	+39.0%	+95.5%	+73.1%
PE Ratio	Nov 12, 26	25.85	+2.5%	+17.9%	+29.7%	+186.9%
TTM Revenue	Sep 30, 26	$11.84B	+2.4%	+9.1%	+27.4%	+7.2%
TTM EPS	Sep 30, 26	$10.04	+6.5%	+17.9%	+50.7%	-39.6%
	Sep 30, 26	$1.75B	+3.9%	+10.2%	+29.9%	-36.1%
TTM Net Income	Sep 30, 26	$1.18B	+6.0%	+15.3%	+44.3%	-48.1%

TTM EBITDA Highs

DGX TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$2.33B	Sep 30, 26	at high
3Y	$2.33B	Sep 30, 26	at high
5Y	$3.13B	N/A	-25.6%
All	$3.26B	Jun 30, 21	-28.4%

TTM EBITDA Lows

DGX TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$2.15B	N/A	+8.7%
3Y	$1.79B	N/A	+30.2%
5Y	$1.79B	Sep 30, 23	+30.2%
All	$38.40M	Mar 31, 97	+5975.5%

TTM EBITDA History

Month	Value	Change
Sep 2026	$2.33B	+3.1%
Jun 2026	$2.26B	+1.9%
Mar 2026	$2.22B	+2.2%
Dec 2025	$2.17B	+1.3%
Sep 2025	$2.15B	+4.2%
Jun 2025	$2.06B	+4.1%
Mar 2025	$1.98B	+3.8%
Dec 2024	$1.91B	+4.9%
Sep 2024	$1.82B	+0.6%
Jun 2024	$1.81B	+0.8%
Mar 2024	$1.79B	-0.7%
Dec 2023	$1.81B	+0.7%
Sep 2023	$1.79B	-2.2%
Jun 2023	$1.83B	-2.2%
Mar 2023	$1.87B	-9.0%
Dec 2022	$2.06B	-10.6%
Sep 2022	$2.30B	-10.3%
Jun 2022	$2.57B	-5.1%
Mar 2022	$2.71B	-5.2%
Dec 2021	$2.86B	-8.9%
Sep 2021	$3.13B	-3.8%
Jun 2021	$3.26B	+9.9%
Mar 2021	$2.96B	+20.3%
Dec 2020	$2.46B	+28.4%
Sep 2020	$1.92B	+33.8%
Jun 2020	$1.43B	-3.4%
Mar 2020	$1.48B	-4.2%
Dec 2019	$1.55B	+2.2%
Sep 2019	$1.52B	+1.4%
Jun 2019	$1.49B	-0.5%
Mar 2019	$1.50B	-2.0%
Dec 2018	$1.53B	-1.7%
Sep 2018	$1.56B	-0.8%
Jun 2018	$1.57B	+0.4%
Mar 2018	$1.57B	+0.9%
Dec 2017	$1.55B	+1.3%
Sep 2017	$1.53B	+1.0%
Jun 2017	$1.52B	+1.3%
Mar 2017	$1.50B	+1.2%
Dec 2016	$1.48B	+0.9%
Sep 2016	$1.47B	-1.1%
Jun 2016	$1.48B	-0.2%
Mar 2016	$1.49B	0.0%
Dec 2015	$1.49B	-1.1%
Sep 2015	$1.50B	+1.4%
Jun 2015	$1.48B	+1.0%
Mar 2015	$1.47B	+2.4%
Dec 2014	$1.43B	+0.5%
Sep 2014	$1.43B	+1.3%
Jun 2014	$1.41B	+0.3%
Mar 2014	$1.40B	-2.2%
Dec 2013	$1.44B	-0.5%
Sep 2013	$1.44B	-4.1%
Jun 2013	$1.50B	-3.1%
Mar 2013	$1.55B	-3.1%
Dec 2012	$1.60B	-2.4%
Sep 2012	$1.64B	+0.0%
Jun 2012	$1.64B	+0.2%
Mar 2012	$1.63B	+2.9%
Dec 2011	$1.59B	+1.6%

Month	Value	Change
Sep 2011	$1.56B	+1.5%
Jun 2011	$1.54B	-0.7%
Mar 2011	$1.55B	-2.1%
Dec 2010	$1.59B	-1.5%
Sep 2010	$1.61B	-0.7%
Jun 2010	$1.62B	+1.3%
Mar 2010	$1.60B	-0.4%
Dec 2009	$1.61B	+0.1%
Sep 2009	$1.60B	+1.9%
Jun 2009	$1.57B	+2.3%
Mar 2009	$1.54B	+2.6%
Dec 2008	$1.50B	+1.6%
Sep 2008	$1.48B	+0.6%
Jun 2008	$1.47B	+3.1%
Mar 2008	$1.42B	+6.0%
Dec 2007	$1.34B	+3.6%
Sep 2007	$1.30B	+2.6%
Jun 2007	$1.26B	-0.1%
Mar 2007	$1.27B	-4.1%
Dec 2006	$1.32B	+1.7%
Sep 2006	$1.30B	+3.8%
Jun 2006	$1.25B	+2.2%
Mar 2006	$1.22B	+4.1%
Dec 2005	$1.18B	+3.6%
Sep 2005	$1.13B	+1.8%
Jun 2005	$1.12B	+2.0%
Mar 2005	$1.09B	+2.1%
Dec 2004	$1.07B	+1.7%
Sep 2004	$1.05B	+2.0%
Jun 2004	$1.03B	+2.8%
Mar 2004	$1.00B	+5.2%
Dec 2003	$954.28M	+7.3%
Sep 2003	$888.96M	+7.5%
Jun 2003	$827.02M	+8.1%
Mar 2003	$765.24M	+5.7%
Dec 2002	$723.84M	+5.4%
Sep 2002	$686.67M	+7.8%
Jun 2002	$636.99M	+7.2%
Mar 2002	$594.04M	+6.2%
Dec 2001	$559.12M	+7.3%
Sep 2001	$521.18M	+4.7%
Jun 2001	$497.97M	+5.1%
Mar 2001	$473.80M	+5.3%
Dec 2000	$449.80M	+3.2%
Sep 2000	$435.85M	+13.3%
Jun 2000	$384.67M	+25.4%
Mar 2000	$306.80M	+24.6%
Dec 1999	$246.17M	+27.1%
Sep 1999	$193.64M	+17.7%
Jun 1999	$164.54M	+2.2%
Mar 1999	$160.97M	-2.8%
Dec 1998	$165.58M	+6.9%
Sep 1998	$154.88M	+0.7%
Jun 1998	$153.74M	-1.7%
Mar 1998	$156.33M	+3.6%
Dec 1997	$150.90M	+22.5%
Sep 1997	$123.20M	+43.9%
Jun 1997	$85.60M	+122.9%
Mar 1997	$38.40M	-

FAQ

What is the current TTM EBITDA of DGX?: As of today, DGX TTM EBITDA is $2.33B
What is DGX TTM EBITDA most recent change?: DGX TTM EBITDA was up +3.09% on September 30, 2026
What is 1-year change in DGX TTM EBITDA?: DGX TTM EBITDA is up +8.71% year-over-year
How far is DGX TTM EBITDA from its all-time high?: DGX TTM EBITDA is currently -28.37% below its historical high of $3.26B set on June 30, 2021
How does DGX TTM EBITDA rank versus sector peers?: DGX TTM EBITDA is higher than 95.17% of companies in Healthcare sector
When is DGX next earnings release?: The next earnings release for DGX is on February 9, 2027

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

DGX Official Website www.questdiagnostics.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1022079/000102207926000005/0001022079-26-000005-index.htm
DGX Profile on Yahoo Finance finance.yahoo.com/quote/DGX
DGX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dgx